Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials

OBJECTIVES: To investigate whether progression-free survival (PFS) can be considered a surrogate endpoint for overall survival (OS) in advanced non-small-cell lung cancer (NSCLC). DESIGN: Meta-analysis of individual patient data from randomised trials. SETTING: Five randomised controlled trials comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Laporte, Silvy, Squifflet, Pierre, Baroux, Noémie, Fossella, Frank, Georgoulias, Vassilis, Pujol, Jean-Louis, Douillard, Jean-Yves, Kudoh, Shinzohy, Pignon, Jean-Pierre, Quinaux, Emmanuel, Buyse, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612819/
https://www.ncbi.nlm.nih.gov/pubmed/23485717
http://dx.doi.org/10.1136/bmjopen-2012-001802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612819/
https://www.ncbi.nlm.nih.gov/pubmed/23485717
http://dx.doi.org/10.1136/bmjopen-2012-001802

Ejemplares similares